 |
Post publication peer
review acknowledgement
|
Department of Immunology research on chronic lymphocytic leukaemia (CLL) has been recommended by the
Faculty of 1000 as being of special significance in its field. The reviewer, Dr Philippe Saas, writes, "these data may explain the vulnerability of CLL patients to viral infections and provide therapeutic approaches (Flt3L plus CpG ODN or anti-TNF plus anti-TGF-beta antibodies) to restore PDC number and PDC capacity to produce type I IFN in peripheral lymphoid tissues." References:
